期刊文献+

GATA2^(−/−) human ESCs undergo attenuatedendothelial to hematopoietic transition andthereafter granulocyte commitment 被引量:2

原文传递
导出
摘要 Background: Hematopoiesis is a progressive process collectively controlled by an elaborate network of transcriptionfactors (TFs). Among these TFs, GATA2 has been implicated to be critical for regulating multiple steps of hematopoiesisin mouse models. However, whether similar function of GATA2 is conserved in human hematopoiesis, especially duringearly embryonic development stage, is largely unknown.Results: To examine the role of GATA2 in human background, we generated homozygous GATA2 knockout humanembryonic stem cells (GATA2^(−/−) hESCs) and analyzed their blood differentiation potential. Our results demonstratedthat GATA2^(−/−) hESCs displayed attenuated generation of CD34^(+)CD43^(+) hematopoietic progenitor cells (HPCs), due tothe impairment of endothelial to hematopoietic transition (EHT). Interestingly, GATA2^(−/−) hESCs retained the potentialto generate erythroblasts and macrophages, but never granulocytes. We further identified that SPI1 downregulationwas partially responsible for the defects of GATA2^(−/−) hESCs in generation of CD34^(+)CD43^(+) HPCs and granulocytes.Furthermore, we found that GATA2^(−/−) hESCs restored the granulocyte potential in the presence of Notch signaling.Conclusion: Our findings revealed the essential roles of GATA2 in EHT and granulocyte development throughregulating SPI1, and uncovered a role of Notch signaling in granulocyte generation during hematopoiesis modeled byhuman ESCs.
出处 《Cell Regeneration》 2015年第1期32-46,共15页 细胞再生(英文)
基金 This work was supported by the following:National Basic Research Program of China,973 Program of China(2012CB966503,2011CB965204,2014CB964604) “Strategic Priority Research Program”of the Chinese Academy of Sciences Grant No.XDA01020202 National Natural Science Foundation of China(31371514,31200970,81301340) National Natural Science Foundation-Guangdong Joint Fund No.U1132005,National S&T Major Special Project on Major New Drug Innovation,Grant No.2011ZX09102010 “Hundred Talents Program”of Chinese Academy of Sciences(to Dr.G Pan) the Equipment Function Development&Technology Innovation Project of the Chinese Academy of Sciences(Grant Nos.yg2012049,yg2011082,and yg2011083)。
  • 相关文献

同被引文献4

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部